Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Asha Hareendran (UCB Biopharma Srl) | Asha Hareendran has received personal compensation for serving as an employee of UCB. Asha Hareendran has stock in UCB. Asha Hareendran has stock in Pfizer. |
| No disclosure on file | |
| No disclosure on file | |
| Sandhya Sapra | No disclosure on file |
| No disclosure on file | |
| Katherine L. Widnell, MD, PhD (UCLA Health Burbank Neurology) | No disclosure on file |
| Martha S. Bayliss | No disclosure on file |
| Dawn C. Buse, PhD (Dawn C. Buse, PhD) | Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation. |
| No disclosure on file |